Adhesive composition for soft tissues, adhesive composition for wound dressing or wound dressing composition

Patent metadata

Field	Value
Publication number	US-9314546-B2
Application number	US-201013508009-A
Country	US
Kind code	B2
Filing date	Nov 18, 2010
Priority date	Nov 20, 2009
Publication date	Apr 19, 2016
Grant date	Apr 19, 2016

Abstract

The adhesive composition for soft tissues, the adhesive composition for wound dressing or the wound dressing agent composition of the present invention is an adhesive composition for soft tissues, an adhesive composition for wound dressing or a wound dressing agent composition, comprising a monomer (A), a polymer (B) and a polymerization initiator composition (C) containing an organoboron compound, and is characterized by having a viscosity of 0.4 to 75,000 cp within 30 seconds after mixing of the components (A), (B) and (C). The composition of the present invention not only has low toxicity, low harmfulness and high adhesive strength but also is excellent in workability during application and is capable of forming films of excellent properties.

First claim

The invention claimed is:

1. An adhesive composition for soft tissues, an adhesive composition for wound dressing or a wound dressing composition, comprising a monomer (A), a (meth)acrylate uncrosslinked polymer (B) and a polymerization initiator composition (C) containing an organoboron compound, and
having a viscosity of 0.4 to 75,000 cp within 30 seconds after mixing of the components (A), (B) and (C),
wherein the polymer (B) is a polymer mixture which comprises polymer particles (b1) having a weight-average molecular weight of 30×10 4 to 60×10 4 and a specific surface area of 1.5 to 4.5 (m 2 /g), polymer particles (b2) having a weight-average molecular weight of 5×10 4 to 20×10 4 and a specific surface area of 0.51 to 1.2 (m 2 /g) and polymer particles (b3) having a weight-average molecular weight of 5×10 4 to 20×10 4 and a specific surface area of 0.1 to 0.5 (m 2 /g), contains the polymer particles (b1) in an amount of 10 to 60% by weight, and contains the polymer particles (b2) and the polymer particles (b3) in the total amount of not less than 2% by weight based on the total weight of the polymer particles (b1), (b2) and (b3), with the proviso that the total amount of the polymer particles (b1), (b2) and (b3) is 100% by weight,
and wherein the amount of the component (B) is in the range of 28 to 55 parts by weight, based on 100 parts by weight of the total amount of the monomer (A), the polymer (B) and the polymerization initiator composition (C).

2. The adhesive composition for soft tissues, the adhesive composition for wound dressing or the wound dressing composition as claimed in claim 1 , wherein a film, which is obtained from said adhesive composition or wound dressing composition, is given 24 hours after the preparation of the composition and has a thickness of not less than 0.1 μm, a length of not less than 25 mm and a width of not less than 2 mm, has a flexural elastic modulus, as measured under the conditions of a test rate of 2 mm/min, of not more than 750 MPa and a tensile elongation, as measured under the conditions of a test rate of 1 mm/min, of not less than 5%.

3. The adhesive composition for soft tissues, the adhesive composition for wound dressing or the wound dressing composition as claimed in claim 1 , which further comprises a polymerization inhibitor (D).

4. The adhesive composition for soft tissues, the adhesive composition for wound dressing or the wound dressing composition as claimed in claim 3 , wherein the content of the polymerization inhibitor (D) is in the range of 10 to 5000 ppm based on the monomer (A).

5. The adhesive composition for soft tissues, the adhesive composition for wound dressing or the wound dressing composition as claimed in claim 3 , wherein the polymerization inhibitor (D) is at least one substance selected from hydroquinone, dibutylhydroquinone, hydroquinone monomethyl ether, 2,6-di-tert-butylphenol, 2,6-di-tert-butyl-p-cresol, catechol, pyrogallol, benzoquinone, 2-hydroxybenzoquinone, p-methoxyphenol, t-butylcatechol, butylated hydroxyanisole, butylated hydroxytoluene and t-butylhydroquinone.

6. The adhesive composition for soft tissues, the adhesive composition for wound dressing or the wound dressing composition as claimed in claim 1 , which further comprises an ultraviolet light absorber.

7. The adhesive composition for soft tissues, the adhesive composition for wound dressing or the wound dressing composition as claimed in claim 1 , which further comprises a plasticizer.

8. The adhesive composition for soft tissues, the adhesive composition for wound dressing or the wound dressing composition as claimed in claim 1 , which further comprises at least one substance selected from:
anti-infectious agents, antibiotics, antibacterial agents, anti-virus agents, analgesics, compositions of analgesics, anorectic drugs, antihelmintic drugs, antiarthritic agents, antiasthmatic drugs, anticonvulsants, antidepressants, antidiuretics, antidiarrheal agents, antihistamine drugs, anti-inflammatory drugs, antimigraine drugs, antiemetic agents, antineoplastic drugs, antiparkinsonian agents, antipruritic drugs, antipsychotics, antipyretic drugs, antispasmodic drugs, anticholinergic agents, sympathomimetic agents, cardiovascular drugs, antiarrhythmic drugs, antihypertensive drugs, diuretics, vasodilators, immunosuppressant drugs, muscle-relaxant drugs, parasympatholytic drugs, stimulants, sedative drugs, tranquilizers, cholinergic agents, chemotherapeutic drugs, radio pharmaceuticals, bone inductive drugs, heparin neutralizer agents of static bladder, procoagulants, hemostatic agents, xanthine derivatives, hormones, proteins of natural origin or proteins synthesized by genetic engineering, polysaccharides, glycoproteins, lipoproteins, oligonucleotides, antibody, antigen, vasopressin, vasopressin analogs, epinephrine, selectin, clot promoting toxicants, plasminogen activating factor inhibitors, platelet activators, synthetic peptides having hemostatic action, and
perfumes, such as orange oil, grapefruit oil, lemon oil, lime oil, clove oil, wintergreen oil, peppermint oil, peppermint spirit, banana distillate, cucumber distillate, honey distillate, rose water, menthol, anethole, alkyl salicylate, benzaldehyde, monosodium glutamate, ethylvanillin, thymol and vanillin.

9. An adhesive kit for soft tissues, an adhesive agent kit for wound dressing or a wound dressing kit, having members in which the components of the monomer (A), the polymer (B) and the polymerization initiator composition (C) containing an organoboron compound, which are contained in the adhesive composition for soft tissues, the adhesive composition for wound dressing or the wound dressing composition as claimed in claim 1 , are encased in two or more divided groups in an optional combination.

10. The adhesive kit for soft tissues, the adhesive kit for wound dressing or the wound dressing kit as claimed in claim 9 , which has constitution in which the monomer (A), the polymer (B) and the polymerization initiator composition (C) are each independently encased, and the monomer (A) is first mixed with the polymerization initiator composition (C) containing an organoboron compound and subsequently mixed with the polymer (B).

11. An adhesive kit for soft tissues, an adhesive agent kit for wound dressing or a wound dressing kit, having members in which the components of the monomer (A), the (meth)acrylate polymer (B), the polymerization initiator composition (C) containing an organoboron compound and the polymerization inhibitor (D), which are contained in the adhesive composition for soft tissues, the adhesive composition for wound dressing or the wound dressing composition as claimed in claim 3 , are encased in two or more divided groups in an optional combination.

12. The adhesive kit for soft tissues, the adhesive kit for wound dressing or the wound dressing kit as claimed in claim 11 , which has constitution in which a mixture of the monomer (A) and the polymerization inhibitor (D), the polymer (B) and the polymerization initiator composition (C) are each independently encased, and the mixture of the monomer (A) and the polymerization inhibitor (D) is first mixed with the polymerization initiator composition (C) containing an organoboron compound and subsequently mixed with the polymer (B).

13. The adhesive kit for soft tissues, the adhesive kit for wound dressing or the wound dressing kit as claimed in claim 9 , which includes a jig that is used for applying a composition obtained by mixing adhesive components or wound dressing components containing the components (A), (B) and (C).

14. The adhesive kit for soft tissues, the adhesive kit for wound dr

Assignees

• Asada Noriaki
• Aoki Shinya
• Naruse Hiroshi
• Miyakoshi Shoichi
• Arata Masami
• Mitsui Chemicals Inc

Inventors

• Asada Noriaki
• Aoki Shinya
• Naruse Hiroshi
• Miyakoshi Shoichi
• Arata Masami

Classifications

• A61L15/58

  Adhesives · CPC title

• A61L15/44 Primary

  Medicaments · CPC title

• A61L24/043 Primary

  Mixtures of macromolecular materials · CPC title

• A61L26/0014

  obtained by reactions only involving carbon-to-carbon unsaturated bonds · CPC title

• A61L15/00

  Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads (for liquid bandages A61L26/00; radioactive dressings {A61N5/1029}) · CPC title